Shire's next deal could be "transformational" - the end?

I see that London-listed Shire has finally formally announced its £22 billion takeover of US rival Baxalta.

Perhaps it's time to start a new series about another FTSE 100 pharmaceutical company's plans to pursue a "transformational" deal?

So, keep an eye on little old Betaville later this week...